Farrell J. Michael's most recent trade in Graphic Packaging Holding Co was a trade of 12,006 Service-Based Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 12,006 | 12,006 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 13,982 | 0 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 13,982 | 142,585 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 8,669 | 145,425 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 15 Feb 2026 | 5,829 | 136,756 (0%) | 0% | 12.4 | 72,396 | Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 4,177 | 145,659 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 4,177 | 4,304 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 15 Feb 2026 | 3,943 | 141,482 (0%) | 0% | 12.4 | 48,972 | Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | SVP, Paperboard Mfg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 15 Feb 2026 | 1,525 | 144,134 (0%) | 0% | 12.4 | 18,941 | Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2026 | 4,991 | 44,921 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 273.78 per share. | 09 Feb 2026 | 4,991 | 466,223 (0%) | 0% | 273.8 | 1,366,436 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.34 per share. | 09 Feb 2026 | 4,991 | 471,214 (0%) | 0% | 146.3 | 730,383 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.34 per share. | 07 Jan 2026 | 4,991 | 471,214 (0%) | 0% | 146.3 | 730,383 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 248.46 per share. | 07 Jan 2026 | 4,991 | 466,223 (0%) | 0% | 248.5 | 1,240,065 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 4,991 | 49,912 | - | - | ResMed Common Stock Options | |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 415 | 17,775 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 251.41 per share. | 08 Dec 2025 | 4,991 | 466,223 (0%) | 0% | 251.4 | 1,254,796 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 4,991 | 54,903 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.34 per share. | 08 Dec 2025 | 4,991 | 471,214 (0%) | 0% | 146.3 | 730,383 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2025 | 33,288 | 33,288 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 13,551 | 473,520 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 20 Nov 2025 | 7,297 | 466,223 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 250.12 per share. | 11 Nov 2025 | 3,459 | 462,175 (0%) | 0% | 250.1 | 865,177 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 250.16 per share. | 11 Nov 2025 | 2,231 | 465,634 (0%) | 0% | 250.2 | 558,109 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 250.18 per share. | 11 Nov 2025 | 2,205 | 459,969 (0%) | 0% | 250.2 | 551,645 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 249.75 per share. | 07 Nov 2025 | 8,011 | 467,866 (0%) | 0% | 249.8 | 2,000,773 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 7,028 | 0 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Nov 2025 | 7,028 | 475,877 (0%) | 0% | 101.6 | 714,326 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Nov 2025 | 983 | 468,849 (0%) | 0% | 101.6 | 99,912 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 983 | 7,028 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Oct 2025 | 8,009 | 475,801 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2025 | 8,009 | 8,011 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 282.85 per share. | 07 Oct 2025 | 8,009 | 467,792 (0%) | 0% | 282.8 | 2,265,332 | ResMed Common Stock |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 382 | 17,318 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 278.14 per share. | 08 Sep 2025 | 8,009 | 467,792 (0%) | 0% | 278.1 | 2,227,590 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 08 Sep 2025 | 8,009 | 475,801 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 8,009 | 16,020 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 12,289 | 467,792 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 8,009 | 24,029 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 279.48 per share. | 07 Aug 2025 | 8,009 | 455,503 (0%) | 0% | 279.5 | 2,238,379 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Aug 2025 | 8,009 | 463,512 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Jul 2025 | 8,009 | 463,512 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 256.72 per share. | 07 Jul 2025 | 8,009 | 455,503 (0%) | 0% | 256.7 | 2,056,076 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2025 | 8,009 | 32,038 | - | - | ResMed Common Stock Options | |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 466 | 16,894 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 8,009 | 40,047 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 251.21 per share. | 09 Jun 2025 | 8,009 | 455,503 (0%) | 0% | 251.2 | 2,011,910 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 09 Jun 2025 | 8,009 | 463,512 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 1,404 | 12,239 | - | - | Restricted Stock Units | |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 810 | 16,427 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2025 | 8,009 | 48,056 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 243.23 per share. | 07 May 2025 | 8,009 | 455,503 (0%) | 0% | 243.2 | 1,948,003 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 May 2025 | 8,009 | 463,512 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 8,009 | 56,065 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Apr 2025 | 8,009 | 463,482 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 209.85 per share. | 07 Apr 2025 | 8,009 | 455,472 (0%) | 0% | 209.9 | 1,680,699 | ResMed Common Stock |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 288 | 15,580 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 8,009 | 64,074 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 229.20 per share. | 07 Mar 2025 | 8,009 | 455,472 (0%) | 0% | 229.2 | 1,835,692 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Mar 2025 | 8,009 | 463,481 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 12,295 | 12,295 | - | - | Service-Based Restricted Stock Unit | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 64,068 | 156,397 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.08 per share. | 22 Feb 2025 | 27,794 | 128,603 (0%) | 0% | 27.1 | 752,662 | Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 16,017 | 0 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 16,017 | 99,312 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.08 per share. | 22 Feb 2025 | 6,983 | 92,329 (0%) | 0% | 27.1 | 189,100 | Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,176 | 85,202 (0%) | 0% | 0 | Common Stock | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,176 | 8,481 | - | - | Service-Based Restricted Stock Units | |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.69 per share. | 15 Feb 2025 | 1,907 | 83,295 (0%) | 0% | 26.7 | 50,898 | Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 236.77 per share. | 07 Feb 2025 | 8,009 | 455,472 (0%) | 0% | 236.8 | 1,896,307 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 07 Feb 2025 | 8,009 | 463,481 (0%) | 0% | 101.6 | 814,035 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 8,009 | 72,083 | - | - | ResMed Common Stock Options | |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 307 | 15,259 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 33,036 | 33,036 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 249.66 per share. | 25 Nov 2024 | 2,000 | 0 (0%) | 0% | 249.7 | 499,330 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 2,000 | 2,090 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 2,000 | 2,000 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 246.26 per share. | 07 Nov 2024 | 14,683 | 464,254 (0%) | 0% | 246.3 | 3,615,821 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 Nov 2024 | 14,683 | 478,937 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 14,683 | 0 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.45 per share. | 07 Nov 2024 | 3,452 | 455,472 (0%) | 0% | 252.4 | 871,443 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.41 per share. | 07 Nov 2024 | 3,101 | 461,152 (0%) | 0% | 252.4 | 782,725 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.48 per share. | 07 Nov 2024 | 2,226 | 458,925 (0%) | 0% | 252.5 | 562,016 | ResMed Common Stock |
| Graphic Packaging Holding Co | Michael J. Farrell | EVP, Mills Division | Sale of securities on an exchange or to another person at price $ 28.99 per share. | 06 Nov 2024 | 25,900 | 81,026 (0%) | 0% | 29.0 | 750,841 | Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 231.91 per share. | 07 Oct 2024 | 14,683 | 464,169 (0%) | 0% | 231.9 | 3,405,206 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 Oct 2024 | 14,683 | 478,852 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 14,683 | 14,683 | - | - | ResMed Common Stock Options | |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 301 | 14,918 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 248.38 per share. | 09 Sep 2024 | 14,683 | 464,169 (0%) | 0% | 248.4 | 3,646,950 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 14,683 | 29,366 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 09 Sep 2024 | 14,683 | 478,852 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 19,272 | 460,071 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 4,098 | 464,169 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2024 | 14,683 | 44,049 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 214.25 per share. | 07 Aug 2024 | 14,683 | 440,799 (0%) | 0% | 214.3 | 3,145,905 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 07 Aug 2024 | 14,683 | 455,482 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2024 | 14,683 | 58,732 | - | - | ResMed Common Stock Options | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 192.97 per share. | 08 Jul 2024 | 14,683 | 440,799 (0%) | 0% | 193.0 | 2,833,330 | ResMed Common Stock |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.98 per share. | 08 Jul 2024 | 14,683 | 455,482 (0%) | 0% | 85.0 | 1,247,761 | ResMed Common Stock |
| Zimmer Biomet Holdings | Michael J. Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 299 | 14,586 | - | - | Phantom Stock Units | |
| ResMed | Michael J. Farrell | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 14,683 | 73,415 | - | - | ResMed Common Stock Options |